This product is for wholesale purchases only.
Bulk orders must meet the 20 unit minimum per item/Per mg. Please contact us directly for bulk pricing. EMAIL
**You will be required to provide proof of a resale certificate within the Health & Wellness industry in order to recieve pricing.
This item has been tested and certified by a USA based 3rd party lab. These documents are available upon request.
- Tirzepatide is dual agonist GLP weight managment supplement via subqutaneous injection.
- Custom branded lables and individual vial boxes are available to showcase your brand. Otherwise these will come blank or with our basic branding and labling, per customer request (Sample image has been provided).
- For branding & pricing please contact us directly to discuss your artwork and requirements.
Production and Delivery:
Blank Vials, no branding bulk pack (7-10 days)
Branded Vials bulk packaged (10-14 days)
Branded Vials and Vial Boxes (20-30 days)
Tirzepatide 10mg | 15mg | 20mg | 30mg
Tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it activates two hormone pathways in the body—GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). These gut hormones are naturally released after eating and help regulate blood sugar and appetite.
How It Works
Tirzepatide mimics the action of GIP and GLP-1 to:
-
Stimulate insulin release from the pancreas when blood sugar levels are elevated
-
Suppress glucagon production in the liver, reducing glucose output
-
Slow gastric emptying, which promotes feelings of fullness and reduces appetite
-
Influence brain regions involved in appetite control and food cravings
Approved Uses
-
Type 2 Diabetes: Tirzepatide is FDA-approved to help adults with type 2 diabetes improve blood sugar control.
-
Chronic Weight Management: Tirzepatide is FDA-approved for adults with obesity or those who are overweight with at least one weight-related condition (e.g., high blood pressure or type 2 diabetes). It is used alongside a reduced-calorie diet and increased physical activity.
-
Obstructive Sleep Apnea (OSA): Tirzepatide is also approved for treating moderate to severe OSA in adults with obesity.
Important Note
Tirzepatide is not approved for the treatment of type 1 diabetes or diabetic ketoacidosis.
-